Study shows efficacy, safety of oral immunotherapy in one- to three-year-olds with peanut allergy - Earth News Report
The majority of young children treated with peanut immunotherapy achieved desensitization after two and a half years of treatment, and one in five remained in remission 26 weeks after treatment ended, according to a randomized controlled trial published in The Lancet. Achieving remission was more common the younger the child was at the start of
